Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

RPG Life Sciences

RPG Life Sciences
1968 FOUNDED
PUBLIC STATUS
1K-5K EMPLOYEES
RPGLIFE STOCK SYMBOL
1 INVESTMENTS
$3.86 SHARE PRICE (As of Thursday Closing)
Description

RPG Life Sciences Ltd is an integrated pharmaceutical company. Its only reportable segment is the manufacturing and marketing of pharmaceutical products. Geographically, it derives a majority of revenue from India. The company operates across Domestic Formulations, International Formulations and Active Pharmaceutical Ingredients (API). It focuses on Nephrology, Oncology, Urology, Respiratory, Gastrointestinal, Cardiovascular, Gynaecology and Pediatrics, Vitamins and Minerals, Pain Management, Neurology, Anti-Dengue, Anti-Diabetic, and Derma.

Formerly Known As
Searle India
Ownership Status
Publicly Held
Financing Status
Corporation
Primary Industry
Pharmaceuticals
Stock Exchange
NSE
Primary Office
  • 463, 4th Floor, RPG HOUSE
  • Dr. Annie Besant Road
  • Worli, 400030
  • India

+91 022 0000 0000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore RPG Life Sciences’s full profile, request a free trial.

RPG Life Sciences Stock Performance

52 wk Range Market Cap Prev. Close EPS Average Volume Shares
$2.10 - $4.95 $63.8M $3.94 $0.24 68.7K 16.5M

RPG Life Sciences Financials Summary

In Thousands,
USD
TTM
31-Dec-2019
FY 2019
31-Mar-2019
FY 2018
31-Mar-2018
FY 2017
31-Mar-2017
Enterprise Value 73,148 65,085 104,596 114,329
Revenue 50,328 47,049 53,213 43,674
EBITDA 7,637 4,892 5,970 4,241
Net Income 3,910 1,544 2,086 3,132
Total Assets 36,176 44,739 38,070
Total Debt 0 5,256 8,328 6,899
Public Fundamental Data provided by Morningstar, Inc. disclaimer

RPG Life Sciences Investments (1)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
000 00000000000000 27-Jul-2016 000000000 00000 00 00.000 Buildings and Property 00. 00000000000
To view this company’s complete investment and acquisition history, request access »